In 2011, Dr. Novack was invited to speak on ophthalmic drug development on several international panels which included senior FDA ophthalmic personnel. These were:

  • Ophthalmology Innovation Summit (Orlando, FL)
  • Glaucoma sub-specialty day at the American Academy of Ophthalmology (Orlando, FL
  • International Symposium on Ocular Pharmacology and Therapeutics (Vienna, Austria)

He also participated in the first ophthalmology workshop of the European Medicines Agency (London, UK).